Prestige Consumer Healthcare (PBH) Stock Forecast & Price Target

$70.68

+0.28 (+0.40%)

(As of 07/26/2024 ET)

Prestige Consumer Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings

Based on 4 Wall Street analysts who have issued ratings for Prestige Consumer Healthcare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for PBH.

Consensus Price Target

$98.25
39.01% Upside

High Forecast	$117.00
Average Forecast	$98.25
Low Forecast	$80.00

According to the 4 analysts' twelve-month price targets for Prestige Consumer Healthcare, the average price target is $98.25. The highest price target for PBH is $117.00, while the lowest price target for PBH is $80.00. The average price target represents a forecasted upside of 39.01% from the current price of $70.68.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$98.25	$98.25	$110.00	$82.00
Forecasted Upside	39.01% Upside	58.03% Upside	86.82% Upside	35.72% Upside

Get Prestige Consumer Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

Ad DTI

How to build the ultimate dividend portfolio

There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.

Click here and I’ll show you how to build the ultimate dividend portfolio.

PBH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PBH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Prestige Consumer Healthcare Stock vs. The Competition

Type	Prestige Consumer Healthcare	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	39.01% Upside	3,123.46% Upside	9.17% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/21/2024	DA Davidson 3 of 5 stars	L. Weiser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$65.00 ➝ $93.00	+42.46%
5/21/2024	Canaccord Genuity Group 1 of 5 stars		Reiterated Rating	Buy ➝ Buy	$80.00 ➝ $80.00	+21.88%
11/15/2023	Royal Bank of Canada 4 of 5 stars		Lower Target	Sector Perform ➝ Sector Perform	$110.00 ➝ $103.00	+74.58%
11/15/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$124.00 ➝ $117.00	+99.12%
6/26/2023	3M Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Reiterates
2/17/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$72.00 ➝ $71.00	+15.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:10 AM ET.

PBH Forecast - Frequently Asked Questions

What is Prestige Consumer Healthcare's forecast for 2024?: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Prestige Consumer Healthcare is $98.25, with a high forecast of $117.00 and a low forecast of $80.00.
Should I buy or sell Prestige Consumer Healthcare stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PBH shares.
Does Prestige Consumer Healthcare's stock price have much upside?: According to analysts, Prestige Consumer Healthcare's stock has a predicted upside of 58.03% based on their 12-month stock forecasts.
Has Prestige Consumer Healthcare been upgraded by Wall Street analysts recently?: Over the previous 90 days, Prestige Consumer Healthcare's stock had 1 upgrade by analysts.
What analysts cover Prestige Consumer Healthcare?: Prestige Consumer Healthcare has been rated by research analysts at Canaccord Genuity Group, and DA Davidson in the past 90 days.
Do Wall Street analysts like Prestige Consumer Healthcare more than its competitors?: Analysts like Prestige Consumer Healthcare more than other "medical" companies. The consensus rating score for Prestige Consumer Healthcare is 2.75 while the average consensus rating score for "medical" companies is 2.72. Learn more on how PBH compares to other companies.